contraindications for glp-1 agonists to glp 1 🕰️60-second review: Mnemonics and Updates in GLP -1 in Non-insulin injectable antidiabetic drugs -

Helmstadter J, Frenis K, Filippou K, et al

GLP-1 Receptor agonist discontinuation among patients with obesity and/or type 2 diabetes

By targeting both receptors, Mounjaro not only helps reduce appetite but also enhances feelings of fullness, supporting more significant weight loss

Market Statistics Key Takeaways By type of GLP-1 agonist drugs, the long-acting GLP-1 agonist segment dominated in 2025

And if youre experiencing brain fog after eating a common sign of post-meal blood sugar dysregulation that article walks through the mechanisms worth investigating

Trials with older GLP-1 drugs (liraglutide, exenatide) including the large ADJUNCT ONE and ADJUNCT TWO studies showed modest HbA1c improvements of 0.10.7%, meaningful weight loss, and lower insulin requirements, but also raised early concerns about hypoglycemia and ketosis that kept enthusiasm in check for years